P150 Once-daily tiotropium Respimat® reduces risk of severe...

Thorax 2015 / 12 Vol. 70; Iss. Suppl 3

P150 Once-daily tiotropium Respimat® reduces risk of severe asthma exacerbation and asthma worsening in symptomatic asthma, independent of allergic and inflammatory status

Dahl, R, Casale, T, Vandewalker, M, Schmidt, H, Engel, M, Moroni-Zentgraf, P, Kerstjens, HAM
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
70
Language:
english
Journal:
Thorax
DOI:
10.1136/thoraxjnl-2015-207770.287
Date:
December, 2015
File:
PDF, 74 KB
english, 2015
Conversion to is in progress
Conversion to is failed